These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16799610)

  • 1. Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):52S-53S; discussion 53S-54S, 60S-65S. PubMed ID: 16799610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):52S-53S; discussion 53S-54S. PubMed ID: 2002265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic aspects of systemic mastocytosis.
    Parker RI
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):557-68. PubMed ID: 10909040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
    Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis.
    Escribano L; Garca-Montero A; Núñez-López R; López-Jiménez J; Almeida J; Prados A; Orfao A
    J Allergy Clin Immunol; 2004 Jul; 114(1):28-33. PubMed ID: 15241340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis in the elderly.
    Butterfield JH; Weiler CR
    Am J Hematol; 2013 May; 88(5):406-8. PubMed ID: 23436294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study.
    Pardanani A; Baek JY; Li CY; Butterfield JH; Tefferi A
    Mayo Clin Proc; 2002 Nov; 77(11):1169-75. PubMed ID: 12440552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of systemic mast cell disease with associated hematologic disorders.
    Travis WD; Li CY; Yam LT; Bergstralh EJ; Swee RG
    Cancer; 1988 Sep; 62(5):965-72. PubMed ID: 3409177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid and hematologic malignancies in 60 patients with systemic mast cell disease.
    Travis WD; Li CY; Bergstralh EJ
    Arch Pathol Lab Med; 1989 Apr; 113(4):365-8. PubMed ID: 2650653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis.
    Sperr WR; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Feb; 127(2):140-2. PubMed ID: 11919425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in the management of systemic mast cell disease.
    Friedman B; Darling G; Norton J; Hamby L; Metcalfe D
    Surgery; 1990 Jan; 107(1):94-100. PubMed ID: 2404352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic mastocytosis].
    Fain O; Stirnemann J; Lortholary O
    Rev Prat; 2005 Oct; 55(15):1629-36. PubMed ID: 16334197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC; Rosenthal NS
    Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):47S-51S; discussion 50S, 60S-65S. PubMed ID: 16799609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic mastocytosis and secondary acute myeloid leukemia].
    Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
    An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic mast cell disease associated with hairy cell leukaemia.
    Petrella T; Depret O; Arnould L; Maynadie M; Guy H; Dalac S; Caillot D; Casasnovas O; Lombard JN
    Leuk Lymphoma; 1997 May; 25(5-6):593-5. PubMed ID: 9250832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.